May 2019

This study evaluates the long-term cost-effectiveness of treatment involving combination therapy with dipeptidyl peptidase 4 (DPP-4) inhibitors and sodium-glucose cotransporter 2 (SGLT2) inhibitors compared with an alternative with sulfonyureas prior to insulin initiation on a background of metformin.

Correction to the Trends From the Field article, “Health Literacy, Preventive Health Screening, and Medication Adherence Behaviors of Older African Americans at a PCMH,” published in the September 2018 issue of The American Journal of Managed Care®.

Brand Logo

259 Prospect Plains Rd, Bldg H
Monroe, NJ 08831

609-716-7777

© 2025 MJH Life Sciences®

All rights reserved.

Secondary Brand Logo